Andreas V Hadjinicolaou

6PUBLICATIONS
27CO-AUTHORS
Behavioural epidemiologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 18, 2026
Endoscopic eradication therapy of Barrett's dysplasia and early adenocarcinoma: where we stand and what's next.

|Apr 12, 2024
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.

Mike B Barnkob, Yale S Michaels, Violaine André

|Sep 29, 2019
Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers.

Adam Barsouk, Prashanth Rawla, Andreas V Hadjinicolaou

|Aug 02, 2019
Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer.

Prashanth Rawla, Adam Barsouk, Andreas V Hadjinicolaou

Pageof 1